Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Citizen Meds vs Synergy Rx

Citizen Meds
Graded #254

Lower grade

vs+12.5
Synergy Rx
Graded #41

Higher grade

The verdict

Synergy Rx takes it — 76.2/100 to 63.7/100.

Synergy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock clinical contact.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCitizen Meds +8
70
62
Dose & formulationSynergy Rx +34
54
88
Clinical oversightSynergy Rx +13
79
92
Labs & monitoringSynergy Rx +14
52
66
FulfillmentSynergy Rx +16
62
78
Contract termsSynergy Rx +13
55
68
Citizen Meds · left barSynergy Rx · right bar

The numbers

MetricCitizen MedsSynergy Rx
WeighScore63.7/10076.2/100
GradeCC
Scorecard rank#254#41
Semaglutide$125/mo (0.25 mg dose, compounded)From $199/mo
Tirzepatide$185/mo (2.5 mg dose, first-month rate, compounded)From $349/mo
CoverageCoverage not publishedNot disclosed
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Citizen Meds

Graded #254 · C

Strengths

  • Semaglutide confirmed from product listings
  • New-patient discount available (code NEWPATIENT10)

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • About page returns a 404
  • Limited overall transparency
Synergy Rx

Graded #41 · C

Strengths

  • Prescribes FDA-approved brand Wegovy, Ozempic and Mounjaro when clinically appropriate
  • Unlimited appointments, unlimited messaging and 24/7 access to a dedicated clinical team
  • $100 welcome credit at checkout, and FSA/HSA eligible

Where it loses points

  • Publishes no GLP-1 price anywhere on its own site
  • At $349/mo tirzepatide sits roughly $100 above the compounded median we track
  • Does not publish which states it serves
  • No published cancellation or refund terms

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard